Study Helps Explain Common Kidney Cancer
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
Scientists have discovered master genes and other genes that together help explain much of the biology of renal cell carcinoma (ccRCC), a common and difficult-to-treat kidney cancer.
The scientists examined the expression of every human gene in clear cell renal cell carcinoma (ccRCC) cells compared to normal kidney cells. They found a biological pathway signature of ccRCC for a group of altered genes that give this distinct cancer its "clear cell" appearance, plus other genes that confer stem cell-like properties to the cancer, and a set of master genes lost in ccRCC that they believe likely pushes initial development of the cancer.
"Understanding these genes and the pathways they regulate could provide valuable insight into how to treat ccRCC," said Mayo Clinic researcher Dr. Han W. Tun, lead author of a report on the findings in the May 18 issue of the the journal PLoS ONE.
This cancer makes up 80 percent of all kidney cancer and is often resistant to both chemotherapy and radiation treatment, Tun said. It accounts for just 3 percent of all cancers in the United States, but is the sixth leading cause of cancer death.
"Up until this point, ccRCC was largely a mystery, but now we have new and exciting clues that seem to reveal the origin and development of this cancer," said study team member John Copland, a cancer biologist at the Mayo Clinic.
The researchers found that 13,729 genes had altered expression in the cancer — a figure Copland calls "just astounding, especially in trying to develop new treatments and in understanding the causes of kidney cancer." They used novel software that grouped these genes into meaningful biological pathways — which helped them discover master genes. Each of these master genes regulates hundreds of "downstream" genes.
The study could help researchers develop better treatments that would involved trying to regulate the behavior of certain genes.
Get the world’s most fascinating discoveries delivered straight to your inbox.
- More Cancer News

